Glenmark Pharmaceuticals's US arm has launched a generic version of Clindamycin Phosphate foam, an antibiotic acne treatment.

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

Antimicrobial resistance is a growing health crisis that could lead to millions of deaths by 2050, according to the World ...

Glenmark Pharmaceuticals Ltd on Wednesday said its US arm has launched the generic version of Clindamycin Phosphate foam, an.

Pseudomonas bacteria infected by different mutations of a jumbo phage. The dot in the middle is the shield created by the ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

The phrase "let your food be your medicine" was attributed to the father of medicine, Hippocrates, and it remains an ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...

Babies born during the COVID-19 pandemic had much lower risk for respiratory infections and antibiotic prescriptions during their first 18 months.

Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients SHIELD II ...

The productivity gap in research widens as male researchers utilize AI more effectively. Targeted interventions are needed to ...